Core Viewpoint - The company, Gushengtang (02273), plans to issue convertible bonds totaling $110 million to optimize its capital structure and enhance shareholder value, with a conversion price set at a premium of approximately 22.23% over the market price on January 26, 2026 [1] Group 1 - The company has entered into a subscription agreement with relevant investors to issue convertible bonds with an initial conversion price of HKD 37.77 per share, compared to the closing price of HKD 30.90 on January 26, 2026 [1] - The expected net proceeds from the issuance of the convertible bonds are approximately $108.7 million, which will be used for share buybacks, the development of AI systems for traditional Chinese medicine and health management, and general working capital [1] Group 2 - The relevant investor is Ginkgo Health Investment Ltd., a Cayman Islands exempt company wholly owned by Boyu Capital Growth Fund I, Pte. Ltd., which is advised by Boyu Capital Group Management Ltd., a private equity fund providing catalytic capital and strategic support in various sectors including technology and healthcare [2]
固生堂(02273)拟发行1.1亿美元的可换股债券